Literature DB >> 7805314

Myasthenia gravis and thymic Hodgkin's disease associated in one patient with familial lymphoproliferative disorders.

L Padua1, M T Palmisani, G Di Trapani, A Evoli, L M Larrocca, P Tonali.   

Abstract

A 38-year-old man affected with generalized myasthenia gravis (MG) was submitted to thymectomy. At surgery thymic Hodgkin's disease (granulomatous thymoma) and an area of thymic hyperplasia were found. Subsequently, after treatment with anticholinesterase and corticosteroids, the patient achieved clinical remission. The development of MG in this patient could be related to the presence of thymic hyperplasia, rather than to the granulomatous thymoma. Family history revealed that a brother of the patient was affected by non-Hodgkin T-cell lymphoma. Human leukocyte antigens (HLA) were identical in the two affected siblings. The present report suggests a possible link between MG and lymphoproliferative disorders whose mechanism still needs to be clarified.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7805314

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  3 in total

1.  Myasthenia gravis remission and anti-AChR ab reduction after immunosuppressive and anti-neoplastic therapy in a patient with thymic Hodgkin's disease.

Authors:  M T Ferrò; T Riccardi; A Montanelli; P Bernasconi; R Mantegazza
Journal:  J Neurol       Date:  2006-09-29       Impact factor: 4.849

2.  Rare association of Hodgkin lymphoma, Graves' disease and myasthenia gravis complicated by post-radiation neurofibrosarcoma: coincidence or genetic susceptibility?

Authors:  Zsófia Simon; Zsuzsa Ress; József Toldi; Anita Trauninger; Zsófia Miltényi; Árpád Illés
Journal:  Int J Hematol       Date:  2009-04-21       Impact factor: 2.490

3.  Myasthenia Gravis Revealing Hodgkin's Lymphoma.

Authors:  Jaouad Yousfi; Fatimazahra Bensalek; Mouna Zahlane; Laila Benjilali; Lamiaa Essaadouni
Journal:  Eur J Case Rep Intern Med       Date:  2021-03-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.